Biologics in the pipeline: large molecules with high hopes or bigger risks?
Zhou
Honghui
H
D000818:Animals; D000911:Antibodies, Monoclonal / Q000009:adverse effects; D061067:Antibodies, Monoclonal, Humanized; D001688:Biological Products / Q000009:adverse effects; D016568:Drugs, Generic; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D001688:Biological Products; D016568:Drugs, Generic; C509303:TGN-1412